Skip to main content

Comparative efficacy and safety of three surgical procedures for the treatment of lumbar disc herniation: a Bayesian-based network analysis

Abstract

Purpose

Existing studies have suggested that the efficacy and safety of tubular microdiscectomy (TMD) and percutaneous transforaminal endoscopic discectomy (TED) for lumbar disc herniation (LDH) are similar to those of open microdiscectomy (OMD). However, there are no head-to-head randomized controlled trials (RCTs) making indirect or integrated comparisons of the efficacy and safety of TMD and TED for LDH. A network meta-analysis (NMA) of RCTs was used to compare the clinical efficacy and safety of OMD, TMD and TED for LDH in this research.

Methods

We systematically searched the Cochrane Library, PubMed, and Embase databases from their inceptions through March 2023 for eligible literature. The following search terms were used: “transforaminal endoscopic discectomy,” “microdiscectomy,” “endoscopic,” “minimally invasive,” “tubular microdiscectomy,” “spinal disease,” and “randomized clinical trial”. The primary outcomes were the Oswestry disability index (ODI) score and the visual analog scale (VAS) score for leg pain, complications, and reoperation. Direct comparison meta-analyses and NMA were carried out.

Results

Eight RCTs (1391 patients) met the inclusion criteria. Pairwise meta-analysis showed that compared to OMD, TED has advantages in terms of VAS score (SMD=-1.10 95% CI − 1.85 to -0.34, P = 0.005) and ODI score (SMD=-5.17 95% CI − 8.04 to -2.31, P = 0.004). In contrast, the comparative analysis revealed no statistically significant differences between TMD and OMD across all outcome measures. By comparing TED to OMD and TMD to OMD, it was found that there was no significant difference in the complication and reoperation rates. NMA indicated that there was no significant difference in any of the outcomes between TED and TMD. Trend analyses of rank probabilities showed the cumulative probabilities of the most effective treatments, as measured by primary outcomes (VAS score, ODI score, reoperation and complication rates), were TED (95%, 77%, 23%, 58%), TMD (4%, 22%, 54%, 36%), and OMD (1%, 1%, 23%, 6%).

Conclusion

For LDH, TED outperformed OMD in clinical efficacy, while TMD matched OMD outcomes. All modalities showed similar complication/reoperation rates. Probabilistic analyses revealed TED as preferable for younger patients (enhanced pain control, shorter stays), whereas TMD better suited elderly comorbid patients for reoperation risk mitigation.

Peer Review reports

Introduction

Sciatica secondary to lumbar disc herniation (LDH) is one of the primary etiologies of chronic low back and leg pain, with a globally increasing prevalence trend [1]. A Medicare cohort study in the United States revealed substantial impacts of this condition on healthcare resource utilization, mental health, and economic burdens including medical expenditures and productivity losses [2]. International clinical guidelines recommend surgical evaluation for LDH patients unresponsive to 12 weeks of standardized conservative treatment [3]. Randomized controlled trial (RCT) data indicate that over 40% of conservatively refractory LDH patients undergo surgical intervention within two years [4, 5].The surgical management system for LDH has evolved over nearly a century. The initial discectomy reported by Mixter and Barr in 1934 [6] was followed by the landmark introduction of open microdiscectomy (OMD) by Caspar and Yasargil in 1977, representing a critical breakthrough in minimally invasive LDH treatment [7, 8]. Recognized for its favorable clinical outcomes, OMD has been established as the “gold standard” for symptomatic LDH [9, 10]. However, this procedure necessitates paraspinal muscle stripping and partial laminectomy, carrying risks of postoperative spinal biomechanical instability, epidural fibrosis, and cerebrospinal fluid leakage [11, 12]. Recent advancements in minimally invasive technologies aim to minimize tissue damage, primarily including microendoscopic discectomy (MED), percutaneous transforaminal endoscopic discectomy (TED), and tubular microdiscectomy (TMD). MED, integrating tubular retractor systems with endoscopic visualization [13], significantly reduces soft tissue trauma compared to conventional open surgery. A prospective controlled study by Apaydin et al. demonstrated MED’s superiority over OMD in pain relief, functional recovery, and quality of life [14]. Nevertheless, its requirement for laminar bone resection may predispose patients to chronic low back pain and segmental instability [15], driving research focus toward more tissue-preserving TED and TMD techniques. Since Kambin’s description of the “safe triangular zone” in the late 1970s [16], transforaminal endoscopic technology has progressively matured. Leveraging high-definition endoscopic imaging and refined instrumentation, TED has gained prominence in LDH management through its natural anatomical corridor approach that maximizes preservation of spinal osseous structures [17,18,19]. Multiple studies confirm TED’s advantages over OMD in reduced hospitalization, lower complication rates, and superior anatomical preservation [20,21,22]. The 2002 introduction of TMD by Greiner-Perth’s team [23] addressed endoscopic visualization limitations through an intermuscular approach replacing subperiosteal dissection, combined with tubular retractors and microsurgical techniques. Emerging evidence highlights TMD’s advantages over OMD in operative duration, intraoperative bleeding, and postoperative recovery [24].

Given that the indications for TMD and TED are similar to those for OMD surgery in patients with LDH [25, 26], surgeons are faced with a dilemma when deciding between these two minimally invasive techniques. A recent meta-review of research showed that the operative effects of TMD or TED and OMD for LDH are essentially equivalent [27]. Due to the lack of head-to-head comparisons between TMD and TED, most of the studies are pairwise meta-analyses of TMD and MD or TED and OMD [28, 29]. When comparing multiple treatment regimens, Bayesian network meta-analysis (NMA) demonstrates distinct advantages over conventional analytical methods. This methodology synthesizes both direct and indirect comparative evidence, and by generating posterior probability distributions, it enables precise discrimination of subtle differences among therapeutic interventions [28, 30]. A NMA on this topic has been performed previously, but the focus of this study was limited to evaluating the surgical complications and did not include an efficacy evaluation [31]. Thus, in the current study, we sought to provide some useful information about the comparison between TMD, TED and OMD through a Bayesian NMA, aiming to help surgeons and patients make the most suitable treatment choice.

Methods

This systematic review was preregistered (PROSPERO CRD42020156123) and conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Detailed compliance with PRISMA is provided in Supplemental Table 1.

Data sources and search strategy

We searched the Embase, Cochrane Central Register of Controlled Trials, and PubMed databases through March 2023 using the following keywords in various combinations: “transforaminal endoscopic discectomy,” “microdiscectomy,” “endoscopic,” “minimally invasive,” “tubular microdiscectomy,” “spinal disease,” and “randomized clinical trial”.

Study selection criteria

Studies were included if they:

  1. 1)

    Enrolled adults aged 18–80 years with LDH requiring surgery.

  2. 2)

    Compared TMD vs. OMD, TED vs. OMD, or TMD vs. TED.

  3. 3)

    Were randomized controlled trials (RCTs) with ≥ 12 months of follow-up.

Studies were excluded if they:

  1. 1)

    Focused on spinal fractures, deformities, infections, or tumors.

  2. 2)

    Were non-RCTs (e.g., observational studies or reviews).

Data extraction

Two investigators extracted data from the eligible studies to evaluate the following outcomes: (1) visual analog scale (VAS) score for leg pain [32]; (2) Oswestry disability index (ODI) score [33]; (3) complications; (4) reoperation rate; and (5) operative time, and length of hospital stay.

Risk of bias assessment and certainty of evidence

Two investigators assessed the risk of bias using twelve criteria recommended by the Cochrane Back Review Group [34]. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to evaluate both the strength of recommendations and the quality of evidence [35].

Data synthesis and analysis

In this study, we chose odds ratios (OR) and standardized mean difference (SMD) 95% confidence intervals (95% CIs) to represent the results of dichotomous outcomes and continuous outcomes. If the 95% CI included 0 for SMD or 1 for OR, there were no significant differences in the result [36].

The analytical protocol was conducted as follows: Initial pairwise meta-analyses comparing TMD/TED versus OMD were performed using RevMan software (Review Manager 5.3 version. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.). Potential heterogeneity across studies was assessed through the inconsistency statistic index derived from forest plot analyses. A random-effects model was employed to pool effect sizes when significant heterogeneity was detected ( > 50%), with a fixed-effect model utilized under homogeneous conditions. In instances of substantial heterogeneity, univariate sensitivity analysis was implemented via sequential exclusion of individual studies to evaluate their influence on overall risk estimates.

To incorporate indirect comparisons, NMA was conducted using ADDIS software (Aggregate Data Drug Information System, version 1.16.5) to compare TED, TMD, and OMD, with calculation of ranking probabilities for indirect treatment effects. The software integrates direct and indirect evidence through common comparators to estimate relative effects in multi-intervention comparisons [37, 38]. ADDIS, a non-programmatic software, employs Markov chain Monte Carlo (MCMC) methods within a Bayesian framework for data evaluation and processing [39]. The parameter configuration in ADDIS was standardized as follows: number of chains = 4, tuning iterations = 20,000, simulation iterations = 50,000, thinning interval = 10, inference samples = 10,000, variance scaling factor = 2.5. Convergence of iterative simulations was evaluated using the potential scale reduction factor (PSRF) computed via the Brooks–Gelman–Rubin method, where PSRF values approaching 1 indicate optimal convergence, with PSRF < 1.2 deemed acceptable [40]. A Bayesian random-effects regression model was implemented in ADDIS 1.16 using MCMC methodology. Additionally, inconsistency standard deviation (ISD) analysis was performed to confirm statistical consistency. The consistency model was adopted if the 95% confidence interval of ISD encompassed 1; otherwise, the inconsistency model was applied [41]. The Bayesian framework enabled probabilistic ranking of treatments (best, second-best, etc.), with endpoint metrics ranked numerically where position 1 denotes least favorable and position N indicates optimal performance.

Results

Eligible studies

By searching the databases, 1130 studies were collected; 580 from EMBASE, 331 from PubMed, and 218 from the Cochrane Central Register of Controlled Trials. Only sixteen RCTs were included [25, 31, 42,43,44,45,46,47,48,49,50,51,52,53,54,55].Three of 16 studies included a follow-up of less than 1 year [43, 44, 50], and five were duplicate reports of the same set of patients [42, 51,52,53,54]. Eight RCTs with 1391 patients were included in the meta-analysis. There were 997, 248, and 558 patients allocated to the OMD, TMD, and TED groups, respectively (Fig. 1). The characteristics of the 8 studies are shown in Table 1 [31, 45,46,47,48,49, 55].

Fig. 1
figure 1

Flow diagram of the study selection process for the meta-analysis

Table 1 Characteristics of the included studies

Risk of bias of individual studies

Figures 6 and 7 shows the risk of bias graph. In the included studies, 7 studies indicated “randomly allocating”. Only 3 trials described methods of randomization. None of the trials mentioned the use of the blinding method because none of the researchers in the studies could perform blinding. Six studies found no other significant sources of bias.

Pooled weighted outcomes and direct meta-analysis

Compared with OMD, TMD was no significant difference in any other aspects (Figs. 2, 3, 4 and 5). Compared with OMD, TED was associated with better functional outcomes (SMD=-5.17 95% CI − 8.04 to -2.31, Fig. 2), better pain relief (SMD=-1.10 95% CI − 1.85 to -0.34, Fig. 3), and shorter hospital stays (SMD=-0.70 95% CI − 1.05 to -0.35). There was no significant difference in any other outcomes (Figs. 4 and 5).

Fig. 2
figure 2

Forest plot for the meta-analysis of ODI scores. [ODI: Oswestry disability index, Std mean differences: standardized mean differences, 95% CI: 95% confidence intervals, Random: random effects model, OMD: open microscope discectomy; TMD: tubular microdiscectomy, TED: percutaneous transforaminal endoscopic discectomy]

Fig. 3
figure 3

Forest plot for the meta-analysis of VAS scores. [VAS: visual analogue scale, Std mean differences: standardized mean differences, 95% CI: 95% confidence intervals, Fixed: fixed effects model, OMD: open microscope discectomy; TMD: tubular microdiscectomy, TED: percutaneous transforaminal endoscopic discectom]

Fig. 4
figure 4

Forest plot for the meta-analysis of complication. [95% CI: 95% confidence intervals, Random: random effects model, OMD: open microscope discectomy; TMD: tubular microdiscectomy, TED: percutaneous transforaminal endoscopic discectom]

Fig. 5
figure 5

Forest plot for the meta-analysis of reoperation. [95% CI: 95% confidence intervals, Fixed: fixed effects model, OMD: open microscope discectomy; TMD: tubular microdiscectomy, TED: percutaneous transforaminal endoscopic discectom]

Network meta-analyses and rank probabilities

We conducted a network meta-analysis to compare OMD, TMD, and TED. According to our results, OMD, TMD, and TED were no significantly different in terms of VAS score, ODI score, complications, reoperation rate, operation time, and length of hospital stay (Table 2).

Table 2 Multiple-treatment comparisons based for ODI, VAS, complication, reoperation, OT, LHS on the network

Using a ranking system that indicates the best treatment probability, we developed a histogram figure (Supplemental Fig. 1) to show the probability of being the best, the second best, and the third best treatment modality. It was found that the treatment with higher values in the histogram had higher probabilities for better outcomes. The cumulative probabilities of TED (95%), TMD (4%), and OMD (1%) and their associations with high levels of pain relief were calculated with the help of the network meta-analysis (Supplemental Fig. 1A). TED (77%), TMD (22%), and OMD (1%) were associated with the highest cumulative probabilities of disability prevention (Supplemental Fig. 1B). In other words, the most likely treatment modality that would have the best clinical efficacy was TED, followed by TMD, and finally OMD. TMD (54%), TED (23%), and OMD (23%) were associated with the lowest cumulative probability of reoperation (Supplemental Fig. 1C). According to the cumulative probabilities, TED (58%), TMD (36%), and OMD (6%) were associated with the lowest complication rates (Supplemental Fig. 1D). That is, TED was the most likely to have the highest safety, followed by TMD and then OMD. TED (56.3%), TMD (39.3%), and OMD (4.4%) were associated with the lowest cumulative probability of a prolonged operation time. TED (87.7%), TMD (10.3%), and OMD (2%) were associated with the lowest cumulative probability of a prolonged hospital stay. These probabilistic rankings, while not achieving statistical significance in direct comparisons, reveal clinically meaningful hierarchies in therapeutic performance. The following discussion contextualizes these findings within surgical biomechanics and patient stratification paradigms, elucidating how procedural nuances may drive observed outcome differentials.

By using the 12 criteria recommended by the Cochrane Back Review Group, we assessed the risk of bias in all the original studies [34]. Figures 6 and 7 show the ratings from all the included studies. An analysis of the funnel plot (Supplemental Fig. 2) revealed no apparent publication bias. As our study had a small sample size, no sensitivity or scenario analysis was conducted.

Fig. 6
figure 6

Risk of bias summary. This risk of bias tool incorporates assessment of randomization (sequence generation and allocation concealment), blinding (participants, personnel and outcome assessors), completeness of outcome data, selection of outcomes reported, and other sources of bias. The items were scored with “yes”, “no”, or “unclear”

Fig. 7
figure 7

Risk of bias graph: judgments about each risk of bias item presented as percentages across all included studies

Sensitivity analysis and quality assessment

Sensitivity analyses were conducted for primary outcomes exhibiting substantial heterogeneity. Our principal methodological approach involved sequential exclusion of lower-quality studies through individual trial removal. Notably, in the complication outcome analysis, exclusion of the study by Gibson et al. [31] resulted in marked reduction of heterogeneity ( decreased from 55 to 0%). A plausible explanation emerges from procedural variability: Gibson’s TED protocol utilized local anesthesia, whereas other included studies employed general anesthesia for TED procedures. This observation suggests potential associations between anesthetic modality selection and complication risk profiles. All pooled outcomes were evaluated using the GRADE quality assessment. The results are shown in Table 3.

Table 3 Summary of findings for the main comparison

Discussion

The discordance between statistical equivalence and probabilistic superiority underscores the need to contextualize these findings through biomechanical rationales and patient-specific considerations, as explored in the following discussion. In this study, we performed a NMA to compare the clinical efficacy and safety of OMD, TMD and TED for LDH. Based on data from eight RCTs, we evaluated the efficacy (in terms of VAS, ODI) and safety (in terms of complication and reoperation rates) of three treatment options for patients with LDH in this study. The NMA indicated that the outcomes of TED and TMD were not significantly different. When relative values fail to reach statistical significance, rank probabilities can be used to analyze a treatment group’s position among certain treatments. It can tell us which treatment would be the most likely option to achieve the best outcomes or if one treatment might be better than another [56]. Our NMA concluded that TED had the greatest probability of ranking first among all three surgical options regarding VAS score, ODI score, complication rate, and operation time, while TMD had the greatest probability of ranking best in terms of reoperation rate.

The ultimate goals for LDH treatments are to eliminate or reduce pain and restore or improve limb function. The direct meta-analysis shows that TMD has no advantages over OMD in terms of pain relief. This conclusion is consistent with the results of previous meta-analyses [28]. Notably, patient-reported VAS score following TED were better than those following OMD. This is in contrast to the findings of Qin’s study [57]. However, although there were 8 RCTs in total, a large portion of the studies did not provide SD values, and the inability to extract valid data led to limited data accuracy. Our NMA results showed no significant differences in VAS and ODI scores among TED, TMD, and OMD treatments, but the rank probabilities revealed a decreasing trend in potential advantages sequentially. One possible reason for this trend is that TED uses the anatomical space to gain access to the internal surgery site, and the musculoskeletal structure is rarely damaged [58]. There is also evidence that paravertebral muscle injuries are associated with poor clinical outcomes [29, 59]. A study that compared preoperative and postoperative serum creatine phosphokinase levels with postoperative low back pain between TED and OMD treatments confirmed that TED was associated with fewer muscle injuries [50]. A study comparing TMD and OMD found no reduction in the incidence of muscle injuries, and patients experienced more low-back pain a year after TMD [42]. Regarding surgical data, the NMA showed that TMD and TED did not differ significantly in terms of operation time and hospitalization days.

In terms of safety, common complications after surgical repair of LDH include cerebrospinal fluid leakage, nerve root injury, and incision-related complications. When OMD was compared with TMD or TED, our NMA showed no reduced risk of complications. These results are in line with previous studies. A meta-analysis found no significant difference in the clinical efficacy of TMD and OMD for LDH in terms of outcomes, reoperation rate or incidence of dural tears [28]. Zhang et al. reported no significant difference in the incidence of complications between TED and OMD for the treatment of LDH [29]. Our NMA found no significant difference in the rate of reoperation between TED and TMD; however, the rank probabilities revealed that compared with TED, TMD was associated with lower incidences of complications and reoperations. One possible reason for these trends is that limited surgical exposure increases the difficulty of surgery, making it easier to cause nerve damage and other complications [60]. Notably, recent technological breakthroughs in the Internet of Things (IoT) have introduced new dimensions in surgical practice. Smart surgical instruments with embedded sensors now enable real-time tissue feedback during discectomy procedures, while wearable IoT devices allow continuous postoperative monitoring of patients’ rehabilitation progress. These innovations are reshaping the landscape of minimally invasive spine surgery [61].

A detailed review of the surgical procedures and technical nuances of TED and TMD may enhance the interpretation of the aforementioned findings. In minimally invasive surgeries for LDH, TMD and TED exhibit distinct technical pathways and intraoperative risks. TMD is typically performed under general anesthesia with the patient prone on a Wilson frame. A 16–20 mm vertical incision is made two fingerbreadths lateral to the midline, followed by sequential dilation to the target intervertebral space using a tubular retractor (18–21 mm diameter). Under microscopic guidance, laminotomy, medial facetectomy, and ligamentum flavum removal are completed, with lateral decompression for severe foraminal stenosis achieved via 2-mm foraminal punches. While this technique minimizes paraspinal muscle dissection through intermuscular approaches, partial facet resection may compromise spinal stability [62]. In contrast, TED employs the TESSYS system (Joimax) through a 5 mm incision 8–14 cm lateral to the midline. The endoscopic channel is established via Kambin’s triangle (bounded by the exiting nerve root, superior endplate of the inferior vertebra, and traversing nerve root), enabling direct visualization for laser or radiofrequency ablation of herniated nucleus pulposus and osteophytes with minimal osseous disruption [63]. However, grade III foraminal stenosis (nerve root collapse) may constrain endoscopic maneuverability, necessitating cautious lateral recess expansion [64].

Intraoperatively, TMD carries a 2–5% risk of dural tears and nerve root irritation due to adjustments in tubular retractor depth [62], while TED poses a 1–3% risk of thermal nerve root injury during laser/radiofrequency application in stenotic foramina [64]. Both techniques require intraoperative fluoroscopic confirmation of instrument trajectories to prevent vascular or visceral injuries. Although both adhere to minimally invasive principles and demonstrate comparable overall efficacy, TED may demonstrate advantages in pain scores (VAS/ODI) due to its avoidance of paraspinal muscle stripping, whereas TMD’s thorough decompression in severe stenosis may reduce reoperation rates [62, 64]. Consequently, TED could be prioritized for younger patients with unilateral radiculopathy due to its potential for superior pain relief and shorter hospitalization, while TMD may be preferred for elderly patients with comorbidities to minimize reoperation risks. Future randomized controlled trials employing standardized surgical protocols are warranted to validate these differences.

Our study had a few potential limitations. First, although all the studies in our study were RCTs, the size of the studies was small, and the total sample size was small. Second, while our initial protocol included quality of life and intraoperative blood loss as exploratory endpoints, insufficient data availability precluded their inclusion in the formal analysis. Future studies should prioritize standardized reporting of these outcomes. Third, substantial heterogeneity emerged from four key sources: (1) Inconsistent postoperative surveillance intervals (12–24 months), compromising longitudinal complication profiling; (2) Technical variability in surgical execution, particularly between legacy (Mayer et al. [48], Hermantin et al. [47]) and contemporary full-endoscopic systems (Ruetten et al. [49], Gibson et al. [31]); (3) Non-standardized allocation concealment methods across trials; (4) Universal absence of independent outcome assessor blinding. Notably, Ruetten’s study also included patients who were treated with an interlaminar endoscopic approach, which is a different procedure from TED. To mitigate these confounders, we implemented a Bayesian random-effects model in the network meta-analysis, which accounts for between-study variability by allowing true treatment effects to differ across studies [65]. Sensitivity analyses were further conducted by excluding studies with high risk of bias. Despite these measures, residual heterogeneity may downgrade the evidence level of this study to Grade II. Last, although this study’s evidence network plot appears to be star-shaped, it does not have a closed loop, which indicates that there are no head-to-head comparisons; thus, the differences in the efficacy and safety of TED and TMD are not statistically significant. Consequently, more RCTs comparing TED with TMD should be conducted to obtain more robust results.

Conclusion

In the comparative analysis of clinical outcomes for LDH treatment, the TED demonstrated superior clinical efficacy over OMD, while TMD exhibited comparable efficacy to OMD. All three surgical modalities exhibited comparable postoperative complication rates and similar reoperation risks. Notably, no significant differences were observed between TED and TMD regarding overall therapeutic efficacy or safety profiles. Probabilistic ranking analyses indicated that TED may serve as the preferred option for younger patients with unilateral radicular symptoms due to its potential advantages in pain alleviation and reduced hospitalization duration. Conversely, TMD may be prioritized for elderly patients with comorbidities to minimize reoperation risks. This conclusion needs to be confirmed in additional well-designed and large-scale RCTs.

Data availability

All data generated or analyzed during this study are included in this published article and its supplementary information files.

References

  1. Ropper AH, Zafonte RD, Sciatica. N Engl J Med. 2015;372:1240–8.

    Article  CAS  PubMed  Google Scholar 

  2. Maslak JP, Jenkins TJ, Weiner JA, Kannan AS, Patoli DM, McCarthy MH, et al. Burden of sciatica on US medicare recipients. J Am Acad Orthop Surg. 2020;28:e433–9.

    Article  PubMed  Google Scholar 

  3. Stochkendahl MJ, Kjaer P, Hartvigsen J, Kongsted A, Aaboe J, Andersen M, et al. National clinical guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy. Eur Spine J. 2017;27:60–75.

    Article  PubMed  Google Scholar 

  4. Peul WC, Hout WBVD, Brand R, Thomeer RTWM, Koes BW, for the Leiden-The Hague Spine Intervention Prognostic Study Group. Prolonged Conservative care versus early surgery in patients with sciatica caused by lumbar disc herniation: two year results of a randomised controlled trial. Br Med J. 2008;336:1355–8.

    Article  Google Scholar 

  5. Weinstein JN, Lurie JD, Tosteson TD, Skinner JS, Hanscom B, Tosteson ANA, et al. Surgical vs nonoperative treatment for lumbar disk herniation: the spine patient outcomes research trial (SPORT) observational cohort. JAMA. 2006;296:2451.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mixter WJ, Barr JS. Rupture of the intervertebral disc with involvement of the spinal Canal. N Engl J Med. 1934;211:210–5.

    Article  Google Scholar 

  7. Yasargil MG. Microsurgical operation of herniated lumbar disc. In: Wüllenweber R, Brock M, Hamer J, Klinger M, Spoerri O, editors. Lumbar disc adult hydrocephalus. Berlin, Heidelberg: Springer Berlin Heidelberg; 1977. pp. 81–81.

    Chapter  Google Scholar 

  8. Caspar W. A new surgical procedure for lumbar disc herniation causing less tissue damage through a microsurgical approach. In: Wüllenweber R, Brock M, Hamer J, Klinger M, Spoerri O, editors. Lumbar disc adult hydrocephalus. Berlin, Heidelberg: Springer Berlin Heidelberg; 1977. pp. 74–80.

    Chapter  Google Scholar 

  9. Casal-Moro R, Castro-Menéndez M, Hernández-Blanco M, Bravo-Ricoy JA, Jorge-Barreiro FJ. Long-term outcome after microendoscopic diskectomy for lumbar disk herniation: A prospective clinical study with a 5-Year Follow-up. Neurosurgery. 2011;68:1568–75.

    Article  PubMed  Google Scholar 

  10. Koebbe CJ, Maroon JC, Abla A, El-Kadi H, Bost J. Lumbar microdiscectomy: a historical perspective and current technical considerations. Neurosurg Focus. 2002;13:1–6.

    Article  Google Scholar 

  11. Katayama Y, Matsuyama Y, Yoshihara H, Sakai Y, Nakamura H, Nakashima S, et al. Comparison of surgical outcomes between macro discectomy and micro discectomy for lumbar disc herniation: A prospective randomized study with surgery performed by the same spine surgeon. J Spinal Disord Tech. 2006;19:344–7.

    Article  PubMed  Google Scholar 

  12. Taylor RS. Spinal cord stimulation in complex regional pain syndrome and refractory neuropathic back and leg pain/Failed back surgery syndrome: results of a systematic review and Meta-Analysis. J Pain Symptom Manage. 2006;31:S13–9.

    Article  PubMed  Google Scholar 

  13. Detwiler PW, Porter RW, Crawford NR, Apostolides PJ, Dickman CA. Lumbosacral junction fixation and fusion after complete L-5 spondylectomy: case report. Neurosurg Focus. 1999;7:E5.

    Article  Google Scholar 

  14. Apaydin AS, BozyiÓit B, Koç-Apaydin Z, GuÓneÓ M, Yana M. Efectos de diferentes tratamientos quirúrgicos sobre El Dolor, La Discapacidad, La Ansiedad y La Calidad de Vida En La hernia de disco lumbar. Cir Cir. 2024;92:13223.

    Google Scholar 

  15. Mostafa Elkatatny AAA, Hamdy TM, Moenes KM. Comparison between results of microdiscectomy and open discectomy in management of High-Level lumbar disc prolapse. Open Access Maced J Med Sci. 2019;7:2851–7.

    Article  Google Scholar 

  16. Kambin P, Sampson S. Posterolateral percutaneous Suction-Excision of herniated lumbar intervertebral discs: report of interim results. Clin Orthop. 1986;207:NA37–43.

    Article  Google Scholar 

  17. Hoogland T, Schubert M, Miklitz B, Ramirez A. Transforaminal posterolateral endoscopic discectomy with or without the combination of a Low-Dose chymopapain: A prospective randomized study in 280 consecutive cases. Spine. 2006;31:E890–7.

    Article  PubMed  Google Scholar 

  18. Yeung AT, Tsou PM. Posterolateral endoscopic excision for lumbar disc herniation: surgical technique, outcome, and complications in 307 consecutive cases. Spine. 2002;27:722–31.

    Article  PubMed  Google Scholar 

  19. Yeung AT, Yeung CA. Advances in endoscopic disc and spine surgery: foraminal approach. Surg Technol Int. 2003;11:255–63.

    PubMed  Google Scholar 

  20. Sivakanthan S, Hasan S, Hofstetter C. Full-Endoscopic lumbar discectomy. Neurosurg Clin N Am. 2020;31:1–7.

    Article  PubMed  Google Scholar 

  21. Liao Z, Chen W, Wang C. Transforaminal percutaneous endoscopic surgery for Far lateral lumbar intervertebral disk herniation. Orthopedics. 2014;37.

  22. Jasper GP, Francisco GM, Telfeian AE. Clinical success of transforaminal endoscopic discectomy with foraminotomy: A retrospective evaluation. Clin Neurol Neurosurg. 2013;115:1961–5.

    Article  PubMed  Google Scholar 

  23. Greiner-Perth R, Böhm H, El Saghir H. Microscopically assisted percutaneous nucleotomy, an alternative minimally invasive procedure for the operative treatment of lumbar disc herniation: preliminary results. Neurosurg Rev. 2002;25:225–7.

    Article  PubMed  Google Scholar 

  24. Chen X, Lin F, Xu X, Chen C, Wang R. Development, validation, and visualization of a web-based nomogram to predict the effect of tubular microdiscectomy for lumbar disc herniation. Front Surg. 2023;10:1024302.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Arts MP. Tubular diskectomy vs conventional microdiskectomy for SciaticaA randomized controlled trial. JAMA. 2009;302:149.

    Article  CAS  PubMed  Google Scholar 

  26. Choi G, Lee S-H, Bhanot A, Raiturker PP, Chae YS. Percutaneous endoscopic discectomy for extraforaminal lumbar disc herniations: extraforaminal targeted fragmentectomy technique using working channel endoscope. Spine. 2007;32:E93–9.

    Article  PubMed  Google Scholar 

  27. Barber SM, Nakhla J, Konakondla S, Fridley JS, Oyelese AA, Gokaslan ZL, et al. Outcomes of endoscopic discectomy compared with open microdiscectomy and tubular microdiscectomy for lumbar disc herniations: a meta-analysis. J Neurosurg Spine. 2019;31:802–15.

    Article  PubMed  Google Scholar 

  28. Wang Y, Liang Z, Wu J, Tu S, Chen C. Comparative clinical effectiveness of tubular microdiscectomy and conventional microdiscectomy for lumbar disc herniation: A systematic review and network Meta-Analysis. Spine. 2019;44:1025–33.

    Article  PubMed  Google Scholar 

  29. Zhang B, Liu S, Liu J, Yu B, Guo W, Li Y, et al. Transforaminal endoscopic discectomy versus conventional microdiscectomy for lumbar discherniation: a systematic review and meta-analysis. J Orthop Surg Res. 2018;13:169.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Rouse B, Chaimani A, Li T. Network meta-analysis: an introduction for clinicians. Intern Emerg Med. 2016;12:103–11.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Gibson JNA, Subramanian AS, Scott CEH. A randomised controlled trial of transforaminal endoscopic discectomy vs microdiscectomy. Eur Spine J. 2016;26:847–56.

    Article  PubMed  Google Scholar 

  32. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983;17:45–56.

    Article  PubMed  Google Scholar 

  33. Fairbank JCT, Pynsent PB. Oswestry Disabil Index: Spine. 2000;25:2940–53.

    CAS  Google Scholar 

  34. Furlan AD, Malmivaara A, Chou R, Maher CG, Deyo RA, Schoene M et al. 2015 Updated Method Guideline for Systematic Reviews in the Cochrane Back and Neck Group: Spine. 2015;40:1660–73.

  35. Grading quality of. Evidence and strength of recommendations. Br Med J. 2004;328:1490.

    Article  Google Scholar 

  36. Higgins JPT. Cochrane handbook for systematic reviews of interventions. Cochrane Collaboration. Cochrane database of systematic reviews (Online). 2011;2011.

  37. Jansen JP, Crawford B, Bergman G, Stam W. Bayesian Meta-Analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. 2008;11:956–64.

    Article  PubMed  Google Scholar 

  38. Salanti G, Higgins JP, Ades A, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res. 2007;17:279–301.

    Article  PubMed  Google Scholar 

  39. Van Valkenhoef G, Tervonen T, Zwinkels T, De Brock B, Hillege H. ADDIS: A decision support system for evidence-based medicine. Decis Support Syst. 2013;55:459–75.

    Article  Google Scholar 

  40. Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graphical Stat. 1998;7:434–55.

    Article  Google Scholar 

  41. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29:932–44.

    Article  CAS  PubMed  Google Scholar 

  42. Arts M, Brand R, Van Der Kallen B, Lycklama À, Nijeholt G, Peul W. Does minimally invasive lumbar disc surgery result in less muscle injury than conventional surgery? A randomized controlled trial. Eur Spine J. 2010;20:51–7.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Pan L, Zhang P, Yin Q. Comparison of tissue damages caused by endoscopic lumbar discectomy and traditional lumbar discectomy: A randomised controlled trial. Int J Surg. 2014;12:534–7.

    Article  PubMed  Google Scholar 

  44. Brock M, Kunkel P, Papavero L. Lumbar microdiscectomy: subperiosteal versus transmuscular approach and influence on the early postoperative analgesic consumption. Eur Spine J. 2008;17:518–22.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Franke J, Greiner-Perth R, Boehm H, Mahlfeld K, Grasshoff H, Allam Y, et al. Comparison of a minimally invasive procedure versus standard microscopic discotomy: a prospective randomised controlled clinical trial. Eur Spine J. 2009;18:992–1000.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Ryang Y-M, Oertel MF, Mayfrank L, Gilsbach JM, Rohde V. STANDARD OPEN MICRODISCECTOMY VERSUS MINIMAL ACCESS TROCAR MICRODISCECTOMY: RESULTS OF A PROSPECTIVE RANDOMIZED STUDY. Neurosurgery. 2008;62:174–82.

    Article  PubMed  Google Scholar 

  47. Hermantin FU, Peters T, Quartararo L, Kambin PA, Prospective. Randomized study comparing the results of open discectomy with those of Video-Assisted arthroscopic Microdiscectomy*†. J Bone Joint Surg Am. 1999;81:958–65.

    Article  CAS  PubMed  Google Scholar 

  48. Mayer HM, Brock M. Percutaneous endoscopic discectomy: surgical technique and preliminary results compared to microsurgical discectomy. J Neurosurg. 1993;78:216–25.

    Article  CAS  PubMed  Google Scholar 

  49. Ruetten S, Komp M, Merk H, Godolias G. Full-Endoscopic interlaminar and transforaminal lumbar discectomy versus conventional microsurgical technique: A prospective, randomized, controlled study. Spine. 2008;33:931–9.

    Article  PubMed  Google Scholar 

  50. Akçakaya MO, Yörükoğlu AG, Aydoseli A, Aras Y, Sabancı PA, Altunrende ME, et al. Serum creatine phosphokinase levels as an indicator of muscle injury following lumbar disc surgery: comparison of fully endoscopic discectomy and microdiscectomy. Clin Neurol Neurosurg. 2016;145:74–8.

    Article  PubMed  Google Scholar 

  51. Ruetten S, Komp M, Merk H, Godolias G. Recurrent lumbar disc herniation after conventional discectomy: A prospective, randomized study comparing Full-endoscopic interlaminar and transforaminal versus microsurgical revision. J Spinal Disord Tech. 2009;22:122–9.

    Article  PubMed  Google Scholar 

  52. Arts MP, Brand R, Van Den Akker ME, Koes BW, Bartels RH, Tan W, et al. Tubular diskectomy vs conventional microdiskectomy for the treatment of lumbar disk herniation: 2-Year results of a Double-Blind randomized controlled trial. Neurosurgery. 2011;69:135–44.

    Article  PubMed  Google Scholar 

  53. Gempt J, Jonek M, Ringel F, Preuß A, Wolf P, Ryang Y. Long-term follow-up of standard microdiscectomy versus minimal access surgery for lumbar disc herniations. Acta Neurochir (Wien). 2013;155:2333–8.

    Article  CAS  PubMed  Google Scholar 

  54. Overdevest GM, Peul WC, Brand R, Koes BW, Bartels RH, Tan WF, et al. Tubular discectomy versus conventional microdiscectomy for the treatment of lumbar disc herniation: long-term results of a randomised controlled trial. J Neurol Neurosurg Psychiatry. 2017;88:1008–16.

    Article  PubMed  Google Scholar 

  55. Gadjradj PS, Rubinstein SM, Peul WC, Depauw PR, Vleggeert-Lankamp CL, Seiger A, et al. Full endoscopic versus open discectomy for sciatica: randomised controlled non-inferiority trial. Br Med J. 2022. e065846.

  56. Ades AE, Sculpher M, Sutton A, Abrams K, Cooper N, Welton N et al. Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis: Pharmacoeconomics. 2006;24:1–19.

  57. Qin R, Liu B, Hao J, Zhou P, Yao Y, Zhang F, et al. Percutaneous endoscopic lumbar discectomy versus posterior open lumbar microdiscectomy for the treatment of symptomatic lumbar disc herniation: A systemic review and Meta-Analysis. World Neurosurg. 2018;120:352–62.

    Article  PubMed  Google Scholar 

  58. Ruetten S, Komp M, Merk H, Godolias G. Use of newly developed instruments and endoscopes: full-endoscopic resection of lumbar disc herniations via the interlaminar and lateral transforaminal approach. J Neurosurg Spine. 2007;6:521–30.

    Article  PubMed  Google Scholar 

  59. Kotil K, Tunckale T, Tatar Z, Koldas M, Kural A, Bilge T. Serum creatine phosphokinase activity and histological changes in the multifidus muscle: a prospective randomized controlled comparative study of discectomy with or without Retraction. J Neurosurg Spine. 2007;6:121–5.

    Article  PubMed  Google Scholar 

  60. Arts MP, Nieborg A, Brand R, Peul WC. Serum creatine phosphokinase as an indicator of muscle injury after various spinal and nonspinal surgical procedures. J Neurosurg Spine. 2007;7:282–6.

    Article  PubMed  Google Scholar 

  61. Mulita F, Verras G-I, Anagnostopoulos C-N, Kotis K. A smarter health through the internet of surgical things. Sens. 2022;22:4577.

    Article  Google Scholar 

  62. Clark AJ, Safaee MM, Khan NR, Brown MT, Foley KT. Tubular microdiscectomy: techniques, complication avoidance, and review of the literature. Neurosurg Focus. 2017;43:E7.

    Article  PubMed  Google Scholar 

  63. Ahn Y. Endoscopic spine discectomy: indications and outcomes. Int Orthop. 2019;43:909–16.

    Article  PubMed  Google Scholar 

  64. Porto GBF, Cisewski SE, Wolgamott L, Frankel BM. Clinical outcomes for patients with lateral lumbar radiculopathy treated by percutaneous endoscopic transforaminal discectomy versus tubular microdiscectomy: A retrospective review. Clin Neurol Neurosurg. 2021;208:106848.

    Article  PubMed  Google Scholar 

  65. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful for the help and support provided by the Fujian Medical University.

Funding

This work was funded by Startup Fund for scientific research, Fujian Medical University (Grant number: 2021QH1037).

Author information

Authors and Affiliations

Authors

Contributions

Jingyu Zhou is the co-first author. Shichao Liu and Jingyu Zhou have contributed equally to this study. Shichao Liu and Jingyu Zhou participated in processes of study design, study selection, data extraction and analysis, writing, and quality evaluation. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Shichao Liu.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Trial registration number

This study is not a clinical trial; therefore, it does not involve providing details of trial registration.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, S., Zhou, J. Comparative efficacy and safety of three surgical procedures for the treatment of lumbar disc herniation: a Bayesian-based network analysis. BMC Surg 25, 125 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12893-025-02856-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12893-025-02856-2

Keywords